Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study
Stroke · 2023
DOI: 10.1161/strokeaha.122.041026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2023. Verfasst von Jiangming Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden (J.S., Y.B., A.E., M.P., O.M., G.E., I.G.). Hauptthemen laut MEDLINE: Stroke, Ischemic Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Mood disorders and strokes are often comorbid, and their health toll worldwide is huge. This study characterizes prognostic and causal roles of mood disorders in stroke.
Methods
We tested if genetic susceptibilities for mood disorders were associated with all strokes, ischemic strokes in the Malmö Diet and Cancer cohort (24 631 individuals with a median follow-up of 21.3 (interquartile range: 16.6–23.2) years. We further examined the causal effects for mood disorders on all strokes and ischemic strokes using summary statistics from large genome-wide association studies of mood disorders (up to 609 424 individuals, Psychiatric Genomics Consortium), all strokes and ischemic strokes (up to 446 696 individuals, MEGASTROKE Consortium).
Results
Among 24 366 stroke-free participants at baseline, 2632 individuals developed strokes, 2172 of them ischemic, during follow-up. After properly adjusting for well-known risk factors, participants in the highest quintile of polygenic risk scores for mood disorders had 1.45× (95% CI, 1.21–1.74) higher risk of strokes and 1.44× (95% CI, 1.18–1.76) higher risk of ischemic strokes compared with the lowest quintile in women. Mendelian randomization analyses suggested that mood disorders had a causal effect on strokes (odds ratio, 1.07 [95% CI, 1.03–1.11]) and ischemic strokes (odds ratio, 1.09 [95% CI, 1.04–1.13]).
Conclusions
Our results suggest a causal role of mood disorders in the risk of stroke. High-risk women could be identified early in life using polygenic risk scores to ultimately prevent mood disorders and strokes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden (J.S., Y.B., A.E., M.P., O.M., G.E., I.G.).
- Department of Cardiology, Skåne University Hospital, Malmö, Sweden (A.E., I.G.).
- Wallenberg Center for Molecular Medicine, Lund University, Sweden (A.E.).
- Lifespan Changes in Bain and Cognition (LCBC), Department of Psychology, University of Oslo, Norway (Y.W., M.P.). Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY.
ORCID-Profile: Jiangming Sun, Yan Borné, Andreas Edsfeldt, Mengyu Pan, Gunnar Engström, Isabel Gonçalves
Zitieren
APA
Sun, J., Borné, Y., Edsfeldt, A., Wang, Y., Pan, M., Melander, O., Engström, G., Gonçalves, I., & Regeneron Genetics Center (2023). Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study. Stroke. https://doi.org/10.1161/strokeaha.122.041026
Vancouver
Sun J, Borné Y, Edsfeldt A, Wang Y, Pan M, Melander O, et al. Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study. Stroke. 2023. doi:10.1161/strokeaha.122.041026
BibTeX
@article{Sun2023,
author = {Sun, Jiangming and Borné, Yan and Edsfeldt, Andreas and Wang, Yunpeng and Pan, Mengyu and Melander, Olle and Engström, Gunnar and Gonçalves, Isabel and Regeneron Genetics Center, Regeneron Genetics Center},
title = {Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study},
journal = {Stroke},
year = {2023},
doi = {10.1161/strokeaha.122.041026}
}
EUVIMED